Enfusion Cash vs Total Liab Analysis
| ENFN Stock | USD 8.80 0.36 3.93% |
Enfusion financial indicator trend analysis is much more than just examining Enfusion latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Enfusion is a good investment. Please check the relationship between Enfusion Cash and its Total Liab accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.
Cash vs Total Liab
Cash vs Total Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Enfusion Cash account and Total Liab. At this time, the significance of the direction appears to have pay attention.
The correlation between Enfusion's Cash and Total Liab is -0.79. Overlapping area represents the amount of variation of Cash that can explain the historical movement of Total Liab in the same time period over historical financial statements of Enfusion, assuming nothing else is changed. The correlation between historical values of Enfusion's Cash and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash of Enfusion are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Cash i.e., Enfusion's Cash and Total Liab go up and down completely randomly.
Correlation Coefficient | -0.79 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Cash
Cash refers to the most liquid asset of Enfusion, which is listed under current asset account on Enfusion balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Enfusion customers. The amounts must be unrestricted with restricted cash listed in a different Enfusion account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Most indicators from Enfusion's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Enfusion current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.At this time, Enfusion's Selling General Administrative is very stable compared to the past year. As of the 7th of June 2024, Sales General And Administrative To Revenue is likely to grow to 0.46, while Tax Provision is likely to drop about 867 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 4.6M | 413K | 1.6M | 2.0M | Depreciation And Amortization | 2.8M | 6.3M | 8.6M | 4.7M |
Enfusion fundamental ratios Correlations
Click cells to compare fundamentals
Enfusion Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Enfusion Stock
When determining whether Enfusion offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enfusion's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enfusion Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enfusion Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.94) | Earnings Share 0.02 | Revenue Per Share 2.055 | Quarterly Revenue Growth 0.173 | Return On Assets 0.0331 |
The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.